A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer.
Clinical trial NCT03469011 · TERMINATED
Trial details
- NCT number
- NCT03469011
- Sponsor
- AHS Cancer Control Alberta
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-18
- Primary completion
- 2024-07-31
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.